893616-55-2 Usage
Uses
Used in Pharmaceutical Industry:
METHYL 2,4-DIHYDROXY-6-METHYLNICOTINATE is used as a pharmaceutical agent for its potential antioxidant and anti-inflammatory properties. It is being studied for its potential role in the treatment of various diseases and conditions, such as neurological disorders, cardiovascular diseases, and certain types of cancer.
Used in Antioxidant Applications:
In the field of medicine and healthcare, METHYL 2,4-DIHYDROXY-6-METHYLNICOTINATE is utilized as an antioxidant, leveraging its ability to scavenge free radicals and reduce oxidative stress. This makes it a candidate for further research and development, particularly in conditions where oxidative stress plays a significant role in disease progression.
Used in Anti-Inflammatory Applications:
METHYL 2,4-DIHYDROXY-6-METHYLNICOTINATE is also used as an anti-inflammatory agent, which can be beneficial in managing inflammation-related conditions and diseases. Its potential in this area is currently under investigation, with the aim of identifying its full therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 893616-55-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,6,1 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 893616-55:
(8*8)+(7*9)+(6*3)+(5*6)+(4*1)+(3*6)+(2*5)+(1*5)=212
212 % 10 = 2
So 893616-55-2 is a valid CAS Registry Number.
893616-55-2Relevant articles and documents
2-Aryloxy-4-alkylaminopyridines: Discovery of novel corticotropin-releasing factor 1 antagonists
Chen, Yuhpyng L.,Obach, R. Scott,Braselton, John,Corman, Michael L.,Forman, James,Freeman, Jody,Gallaschun, Randall J.,Mansbach, Robert,Schmidt, Anne W.,Sprouse, Jeffrey S.,Tingley III, F. David,Winston, Elizabeth,Schulz, David W.
, p. 1385 - 1392 (2008/09/20)
An orally active clinical candidate of corticotropin-releasing factor 1 (CRF1) antagonist 1 showed a significant positive food effect in dog and human after oral administration. Efforts to address the food effect issue led us to explore and dis
